medigraphic.com
ISSN 1816-8450 (Print)

2014, Number 1

<< Back

Geroinfo 2014; 9 (1)

Tumor carcinoide típico

León VYJ, Sánchez ORB, Días GD, García de la Paz OM, Enriquez AC

Language: Spanish
References: 22
Page: 9
PDF size: 134.44 Kb.


ABSTRACT

Case of a typical carcinoid tumor, in a 73-year-old patient, in the Hospital Juridical Beneficent Neumological, that manifests the atypical of a process tumoral. The importance recognized of carrying out a detailed clinical history, a meticulous physical exam and the appropriate employment of the diagnostic means for the diagnosis of entities that being typical histopathologically, they presented clinically in a non-typical way in this population. You concluded that the clinical diagnosis belonged together with the, b histopathological, assign us of that we always think that it was a tumor of low malignancy, but the probability that it was a tumor typical carcinoid, for us it was tiny.


REFERENCES

  1. F. Ignacio Aranda, Cristina Alenda, Francisca M. Peiró, Gloria Peiró Revista española de patologíaVol. 36, n.º 4, 2003.

  2. Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB Jr, Nieman L, Chrousos G, Pass H, Doppman J. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometry study of 35 cases. Am J SurgPathol 1991; 15: 529-53.

  3. Vuitch F, Sekido Y, Fong K, Mackay B, Minna JD, Gazdar AF. Neuroendocrine tumors of the lung. Pathology and molecular biology. Chest SurgClin N Am 1997; 7: 21-47.

  4. Travis WD, Rush W, Flieder DB, Falk R, Fleming MV, Gal AA, Koss MN. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J SurgPathol 1998; 22: 934-44.

  5. Younossian AB, Brundler MA, Totsch M. Feasibility of the new WHO classification of pulmonary neuroendocrine tumours. Swiss Med Wkly 2002; 132: 535-40.

  6. Bensch KG, Corrin B, Pariente R, Spencer H. Oat-cell carcinoma of the lung. Itsorigin and relationshiptobronchialcarcinoid. Cancer 1968; 22: 1163-72.

  7. Fisher ER, Palekar A, Paulson JD. Comparative histopathologic, histochemical, electron microscopic and tissue culture studies of bronchial carcinoids and oat cell carcinomas of lung. Am J ClinPathol 1978; 69: 165-72.

  8. Engelbrech-Holm J. Benign bronchial adenomas. Acta ChirScan 1944; 90: 383- 409.

  9. Arrigoni MG, Woolner LB, Bernatz PE. Atypical carcinoid tumors of the lung. J ThoracCardiovascSurg 1972; 64: 413-421.

  10. Travis WD, Colby T, Corrin B, Shimosato Y, Brambilla E. Histological typing of lung and pleural tumours. World Health Organization International Histological Classification of Tumours. 3rd ed., Berlin: Spriger-Verlag; 1999.

  11. Gosney JR. Endocrine pathology of the lung. En: Antony PP, McSween RNM, editors. RecentAdvances in Hispathology, n.º 16. Edinburg: Churchill-Livinstone; 1994.

  12. Colby TV, Koss MN, Travis WD, editors. Tumors of the lower respiratory tract. Atlas of Tumor Pathology, third series, Washington DC: AFIP; 1995.

  13. Hage R, de la Riviere AB, Seldenrijk CA, van den Bosch JM. Update in pulmonary carcinoid tumors: a review article. Ann SurgOncol 2003; 10: 697-704.

  14. Fink G, Krelbaum T, YellinA, Bendayan D, Saute M, Glazer M, Kramer MR. Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest 2001; 119: 1647-51.

  15. Oliveira AM, Tazelaar HD, Wentzlaff KA, Kosugi NS, Hai N, Benson A, Miller DL, Yang P. Familial pulmonary carcinoid tumors. Cancer 2001; 91: 2104-9.

  16. Zwiebel BR, Austin JH, Grimes MM. Bronchial carcinoid tumors: assessment with CT of location and intratumoral calcification in 31 patients. Radiology 1991; 179: 483-6.

  17. Garcia-Yuste M, Matilla JM, Alvarez-Gago T, Duque JL, Heras F, Cerezal LJ, Ramos G. Prognosticfactors in neuroendocrinelungtumors: a SpanishMulticenterStudy. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR). Ann ThoracSurg 2000; 70: 258-63.

  18. Huang Q, Muzitansky A, Mark EJ. Pulmonary neuroendocrine carcinomas. A review of 234 cases and a statistical analysis of 50 cases treated at one institution using a simple clinicopathologic classification. ArchPatholLab Med 2002; 126: 545- 53.

  19. Thomas CF Jr, Tazelaar HD, Jett JR. Typical and atypical pulmonary carcinoids: outcome in patients presenting with regional lymph node involvement. Chest 2001; 119: 1143-50.

  20. Granberg D, Eriksson B, Wilander E, Grimfjard P, Fjallskog ML, Oberg K, Skogseid B. Experience in treatment of metastatic pulmonary carcinoid tumors. Ann Oncol 2001; 12: 1383-91.

  21. Filosso PL, Ruffini E, Oliaro A, Papalia E, Donati G, Rena O. Long-term survival of atypical bronchial carcinoids with liver metastases, treated with octreotide. Eur J CardiothoracSurg 2002; 21: 913-7.

  22. Gaffey MJ, Mills SE, Frierson HF Jr, Askin FB, MaygardenSJ. Pulmonary clear cell carcinoid tumor: another entity in the differential diagnosis of pulmonary clear cell neoplasia. Am J SurgPathol 1998; 22: 1020-5.




2020     |     www.medigraphic.com